219343

Cathepsin S, Human, Recombinant, E. coli

Cathepsin S, Human, Recombinant, E. coli, is prepared without a tag or fusion protein. A major lysosomal cysteine proteinase with high specific activity.

• Synonim(y): Cathepsin S Protein
• Numer WE: 3.4.22.27 (BRENDA, IUBMB)
• NACRES: NA.77
• UNSPSC Code: 12352202
• Form: liquid
• Assay: ≥90% (SDS-PAGE)
• Biological source: human
• Recombinant: expressed in E. coli

Właściwości

• Quality Level: 100
• biological source: human
• recombinant: expressed in E. coli
• assay: ≥90% (SDS-PAGE)
• form: liquid
• specific activity: ≥30,000 mU/mg protein
• manufacturer/tradename: Calbiochem^®
• storage condition: OK to freeze, avoid repeated freeze/thaw cycles
• technique(s): cell based assay: suitable
• Protein ID accession no.: AAC37592, AAH02642
• UniProt accession no.: P25774
• shipped in: wet ice
• storage temp.: −70°C
• Gene Information: human ... CTSS(1520)

Opis

General description

Note: 1 mU = 1 milliunit.

Research area: Cell Signaling

Recombinant, human cathepsin S expressed in E. coli without a tag or fusion protein. A major lysosomal cysteine proteinase that is preferentially expressed in macrophages and microglia. Shown to be involved in the processing of antigenic peptides for presentation by MHC Class II molecules on the surface of antigen-presenting cells by mediating invariant (Ii) chain degradation. Inhibition of cathepsin S results in impaired antigen-presentation.

Application

Cathepsin S, Human, Recombinant, E. coli has been used in cathepsin digestion reactions.[1]

Biochem/physiol Actions

Cathepsin S is a cysteine protease that plays a role in degradation of class II complexes in human B lymphocytes. It possesses endoproteolytic activity and aids in processing and presenting antigens to immune cells, thereby influencing the immune response. Cathepsin S is involved in facilitating the degradation of damaged or unwanted proteins within the endo-lysosomal pathway. Dysregulation of Cathepsin S activity leads to the development of various diseases such as arthritis, cancer, and cardiovascular diseases.

Physical form

In 35 mM MES, 35 mM sodium acetate, 2 mM DTT, 2 mM EDTA, 50% ethylene glycol, pH 6.4.

Preparation Note

Following initial thaw, aliquot and freeze (-70°C).

Other Notes

Liuzzo, J.P., et al. 1999. Mol. Med.5, 334.
Riese, R.J., et al. 1998. J. Clin. Invest.101, 2351.
Sukhova, G.K., et al. 1998. J. Clin. Invest.102, 576.
Kirschke, H., and Wiederanders, B. 1994. Methods Enzymol.244, 500.
Xin, X.Q., et al. 1992. Arch. Biochem. Biophys.299, 334.
Kirschke, H., et al. 1989. Biochem. J.264, 467.

One unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol Z-VVR-AMC per min at 37°C, pH 6.5. Note: 1 mU = 1 milliunit.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Harmful (C)

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H373
• pcodes: P260 - P264 - P270 - P301 + P312 - P314 - P501
• Hazard Classifications: Acute Tox. 4 Oral - STOT RE 2 Oral
• target_organs: Kidney
• Klasa składowania: 10 - Combustible liquids
• wgk: WGK 1